Titan Pharmaceuticals Stock Buy Hold or Sell Recommendation
| TTNP Stock | USD 6.97 0.04 0.57% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Titan Pharmaceuticals is 'Strong Sell'. Macroaxis provides Titan Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TTNP positions. The advice algorithm takes into account all of Titan Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Titan Pharmaceuticals' buy or sell advice are summarized below:
Real Value 6.49 | Hype Value 6.85 | Market Value 6.97 | Naive Value 6.68 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Titan Pharmaceuticals given historical horizon and risk tolerance towards Titan Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Titan Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Titan |
Execute Titan Pharmaceuticals Buy or Sell Advice
The Titan recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Titan Pharmaceuticals. Macroaxis does not own or have any residual interests in Titan Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Titan Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Titan Pharmaceuticals Trading Alerts and Improvement Suggestions
| Titan Pharmaceuticals is way too risky over 90 days horizon | |
| Titan Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Titan Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 184 K. Net Loss for the year was (5.57 M) with loss before overhead, payroll, taxes, and interest of (4.37 M). | |
| Titan Pharmaceuticals currently holds about 6.42 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Titan Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders |
Titan Pharmaceuticals Returns Distribution Density
The distribution of Titan Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Titan Pharmaceuticals' future price movements. The chart of the probability distribution of Titan Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Titan Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Titan Pharmaceuticals returns is essential to provide solid investment advice for Titan Pharmaceuticals.
| Mean Return | 0.62 | Value At Risk | -8.71 | Potential Upside | 9.20 | Standard Deviation | 6.22 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Titan Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Titan Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Titan Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Titan Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Titan stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.58 | |
β | Beta against NYSE Composite | 0.46 | |
σ | Overall volatility | 6.22 | |
Ir | Information ratio | 0.09 |
Titan Pharmaceuticals Volatility Alert
Titan Pharmaceuticals is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Titan Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Titan Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Titan Pharmaceuticals Fundamentals Vs Peers
Comparing Titan Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Titan Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Titan Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Titan Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Titan Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Titan Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Titan Pharmaceuticals to competition |
| Fundamentals | Titan Pharmaceuticals | Peer Average |
| Return On Equity | -1.39 | -0.31 |
| Return On Asset | -0.75 | -0.14 |
| Operating Margin | (39.55) % | (5.51) % |
| Current Valuation | 214.78 K | 16.62 B |
| Shares Outstanding | 914.23 K | 571.82 M |
| Shares Owned By Insiders | 45.46 % | 10.09 % |
| Shares Owned By Institutions | 5.51 % | 39.21 % |
| Number Of Shares Shorted | 3.91 K | 4.71 M |
| Price To Earning | (3.60) X | 28.72 X |
| Price To Book | 1.00 X | 9.51 X |
| Price To Sales | 36.07 X | 11.42 X |
| Revenue | 184 K | 9.43 B |
| Gross Profit | (4.37 M) | 27.38 B |
| EBITDA | (7.17 M) | 3.9 B |
| Net Income | (5.57 M) | 570.98 M |
| Cash And Equivalents | 6.42 M | 2.7 B |
| Cash Per Share | 0.44 X | 5.01 X |
| Total Debt | 565 K | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 3.06 X | 2.16 X |
| Book Value Per Share | 8.50 X | 1.93 K |
| Cash Flow From Operations | (7.09 M) | 971.22 M |
| Short Ratio | 0.33 X | 4.00 X |
| Earnings Per Share | (7.41) X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | 1.35 | -0.15 |
| Market Capitalization | 6.41 M | 19.03 B |
| Total Asset | 8.09 M | 29.47 B |
| Retained Earnings | (391.83 M) | 9.33 B |
| Working Capital | 6.57 M | 1.48 B |
| Current Asset | 12.24 M | 9.34 B |
| Current Liabilities | 4.85 M | 7.9 B |
Note: Disposition of tradable shares by Flores Francisco of Titan Pharmaceuticals subject to Rule 16b-3 [view details]
Titan Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Titan . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0284 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 6.95 | |||
| Day Typical Price | 6.96 | |||
| Market Facilitation Index | 0.2 | |||
| Period Momentum Indicator | (0.04) |
About Titan Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Titan Pharmaceuticals? Buying financial instruments such as Titan Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Titan Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Titan Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.